Azimilide: Difference between revisions
Content deleted Content added
name change |
m Robot: Automated text replacement (-{{Maintenance|class=Stub|project1=Chemistry|project2=Molecular and Cellular Biology|project3=Pharmacology}} +{{molecular-cell-biology-stub}}\n{{pharm-stub}}) |
||
| Line 10: | Line 10: | ||
'''Azimilide''' an investigational [[antiarrhythmic_drug|class III anti-arrhythmic drug]] that blocks fast and slow components of the delayed rectifier [[heart|cardiac]] [[potassium channel]]s. It is not approved for use in any country. |
'''Azimilide''' an investigational [[antiarrhythmic_drug|class III anti-arrhythmic drug]] that blocks fast and slow components of the delayed rectifier [[heart|cardiac]] [[potassium channel]]s. It is not approved for use in any country. |
||
{{molecular-cell-biology-stub}} |
|||
{{Maintenance|class=Stub|project1=Chemistry|project2=Molecular and Cellular Biology|project3=Pharmacology}} |
|||
{{pharm-stub}} |
|||
[[Category:Antiarrhythmic agents]] |
[[Category:Antiarrhythmic agents]] |
||
Revision as of 23:19, 8 December 2006
Azimilide an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. It is not approved for use in any country.
 | This molecular or cell biology article is a stub. You can help Wikipedia by expanding it. |
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |